{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:39:38Z","timestamp":1790912378138,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals","doi-asserted-by":"publisher","award":["220114"],"award-info":[{"award-number":["220114"]}],"id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cmi.2026.01.002","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T23:35:42Z","timestamp":1768088142000},"page":"845-852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prevalence and clinical outcomes of respiratory syncytial virus, COVID-19, and influenza among older hospitalized adults: the EVERY prospective cohort study"],"prefix":"10.1016","volume":"32","author":[{"given":"Takeshi","family":"Morimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Imura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Nezu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenya","family":"Hamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2026.01.002_bib1","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/infdis\/jis415","article-title":"Mortality attributable to 9 common infections: significant effect of influenza A, respiratory syncytial virus, influenza B, norovirus, and parainfluenza in elderly persons","volume":"206","author":"van Asten","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2026.01.002_bib2","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1016\/S2214-109X(24)00046-9","article-title":"Excess vaccine-preventable disease mortality due to COVID-19","volume":"12","author":"Thompson","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.cmi.2026.01.002_bib3","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1056\/NEJMoa070844","article-title":"Effectiveness of influenza vaccine in the community-dwelling elderly","volume":"357","author":"Nichol","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2026.01.002_bib4","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(05)67339-4","article-title":"Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review","volume":"366","author":"Jefferson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2026.01.002_bib5","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2026.01.002_bib6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0140-6736(23)02467-4","article-title":"Undervaccination and severe COVID-19 outcomes: meta-analysis of national cohort studies in England, Northern Ireland, Scotland, and Wales","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2026.01.002_bib7","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/infdis\/jit839","article-title":"Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness","volume":"209","author":"Falsey","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cmi.2026.01.002_bib8","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/thoraxjnl-2018-212212","article-title":"Respiratory syncytial virus (RSV): a scourge from infancy to old age","volume":"74","author":"Coultas","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2026.01.002_bib9","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2026.01.002_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55599","article-title":"Hospital outcomes of community-acquired SARS-CoV-2 omicron variant infection compared with influenza infection in Switzerland","volume":"6","author":"Portmann","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2026.01.002_bib11","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jamainternmed.2024.7452","article-title":"Severity and long-term mortality of COVID-19, influenza, and respiratory syncytial virus","volume":"185","author":"Bajema","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2026.01.002_bib12","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciad660","article-title":"Outcomes of SARS-CoV-2 omicron variant infections compared with seasonal influenza and respiratory syncytial virus infections in adults attending the emergency department: a multicenter cohort study","volume":"78","author":"Hedberg","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.01.002_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-081037","article-title":"Rationale and protocol for a prospective cohort study of respiratory viral infections in patients admitted from emergency departments of community hospitals: effect of respiratory virus infection on EmeRgencY admission (EVERY) study","volume":"14","author":"Morimoto","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2026.01.002_bib14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.jiac.2024.07.005","article-title":"Prevalence and prognostic impact of respiratory syncytial virus among hospitalized patients with acute respiratory symptoms during July-December 2023 in Japan","volume":"30","author":"Nakamura","year":"2024","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.cmi.2026.01.002_bib15","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.cmi.2017.11.018","article-title":"Multiplex PCR system for the rapid diagnosis of respiratory virus infection: systematic review and meta-analysis","volume":"24","author":"Huang","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2026.01.002_bib16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2026.01.002_bib17","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/cid\/ciab595","article-title":"Incidence of respiratory syncytial virus infection among hospitalized adults, 2017-2020","volume":"74","author":"Branche","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2026.01.002_bib18","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S2213-2600(24)00255-8","article-title":"Respiratory syncytial virus infections in adults: a narrative review","volume":"12","author":"Wildenbeest","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2026.01.002_bib19","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV prefusion F vaccine in older adults","volume":"388","author":"Walsh","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cmi.2026.01.002_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.50832","article-title":"Estimated vaccine effectiveness for respiratory syncytial virus-related lower respiratory tract disease","volume":"7","author":"Tartof","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2026.01.002_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.4954","article-title":"Severity of respiratory syncytial virus vs COVID-19 and influenza among hospitalized US adults","volume":"7","author":"Surie","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.cmi.2026.01.002_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cid\/ciy991","article-title":"Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults","volume":"69","author":"Ackerson","year":"2019","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X26000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:45:23Z","timestamp":1775843123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X26000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1198743X26000029"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2026.01.002","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and clinical outcomes of respiratory syncytial virus, COVID-19, and influenza among older hospitalized adults: the EVERY prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2026.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}